{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T05:08:28Z","timestamp":1788671308651,"version":"build-2803163510"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,4,27]],"date-time":"2016-04-27T00:00:00Z","timestamp":1461715200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s10067-016-3288-8","type":"journal-article","created":{"date-parts":[[2016,4,26]],"date-time":"2016-04-26T21:56:10Z","timestamp":1461707770000},"page":"1529-1533","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Risk factors for malignancy in systemic sclerosis patients"],"prefix":"10.1007","volume":"35","author":[{"given":"T.","family":"Ka\u015fifo\u011flu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u015e.","family":"Ya\u015far Bilge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Y\u0131ld\u0131z","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"\u00d6zen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Pehlivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Y\u0131lmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Tarhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Y\u0131lmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"K\u00fc\u00e7\u00fck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Emmungil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. S.","family":"Koca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"\u00c7\u0131nar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Direskeneli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Erken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Can","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"\u00d6zmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"G\u00f6n\u00fcll\u00fc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Kisacik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Aksu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Karada\u011f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Kasifoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Arslantas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Sahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Keser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Yavuz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Birlik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. M.","family":"Onat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,4,27]]},"reference":[{"key":"3288_CR1","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1136\/ard.2009.114264","volume":"69","author":"AJ Tyndall","year":"2010","unstructured":"Tyndall AJ, Bannert B, Vonk M, Air\u00f2 P, Cozzi F, Carreira PE et al (2010) Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis 69:1809\u201315","journal-title":"Ann Rheum Dis"},{"key":"3288_CR2","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.autrev.2012.02.021","volume":"11","author":"\u00c9 Szekanecz","year":"2012","unstructured":"Szekanecz \u00c9, Szamosi S, Horv\u00e1th \u00c1, N\u00e9meth \u00c1, Juh\u00e1sz B, Sz\u00e1nt\u00f3 J et al (2012) Malignancies associated with systemic sclerosis. Autoimmun Rev 11:852\u20135","journal-title":"Autoimmun Rev"},{"key":"3288_CR3","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00296-009-1348-y","volume":"31","author":"K Siau","year":"2011","unstructured":"Siau K, Laversuch CJ, Creamer P, O\u2019Rourke KP (2011) Malignancy in scleroderma patients from southwest England: a population-based cohort study. Rheumatol Int 31:641\u20135","journal-title":"Rheumatol Int"},{"key":"3288_CR4","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/SMJ.0b013e31815838ce","volume":"101","author":"M Wooten","year":"2008","unstructured":"Wooten M (2008) Systemic sclerosis and malignancy: a review of the literature. South Med J 101:59\u201362","journal-title":"South Med J"},{"key":"3288_CR5","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/j.1365-2133.2010.09861.x","volume":"163","author":"AB Olesen","year":"2010","unstructured":"Olesen AB, Svaerke C, Farkas DK, S\u00f8rensen HT (2010) Systemic sclerosis and the risk of cancer: a nationwide population-based cohort study. Br J Dermatol 163:800\u20136","journal-title":"Br J Dermatol"},{"key":"3288_CR6","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1002\/art.37969","volume":"65","author":"A Onishi","year":"2013","unstructured":"Onishi A, Sugiyama D, Kumagai S, Morinobu A (2013) Cancer induced in systemic sclerosis: meta-analysis of population-based cohort studies. Arthritis Rheum 65:1913\u201321","journal-title":"Arthritis Rheum"},{"key":"3288_CR7","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/rheumatology\/kes303","volume":"52","author":"M Bonifazi","year":"2013","unstructured":"Bonifazi M, Tramacere I, Pomponio G, Gabrielli B, Avvedimento EV, La Vecchia C et al (2013) Systemic sclerosis (scleroderma) and cancer risk: systematic review and meta-analysis of observational studies. Rheumatology (Oxford) 52:143\u201354","journal-title":"Rheumatology (Oxford)"},{"key":"3288_CR8","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.2169\/internalmedicine.51.7686","volume":"51","author":"A Hashimato","year":"2012","unstructured":"Hashimato A, Arinuma Y, Nagai T, Tanaka S, Matsui T, Tohma S et al (2012) Incidence and the risk factor of malignancy in Japanese patients with systemic sclerosis. Intern Med 51:1683\u20138","journal-title":"Intern Med"},{"key":"3288_CR9","first-page":"1705","volume":"26","author":"J Askling","year":"1999","unstructured":"Askling J, Barrett J, Symmons D (1999) Risk of developing certain malignancies is related to duration of immunosuppressive drug exposure in patients with rheumatic diseases. J Rheumatol 26:1705\u201314","journal-title":"J Rheumatol"},{"issue":"1A","key":"3288_CR10","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/0002-9343(85)90245-1","volume":"78","author":"LJ Kinlen","year":"1985","unstructured":"Kinlen LJ (1985) Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment. Am J Med 78(1A):44\u20139","journal-title":"Am J Med"},{"key":"3288_CR11","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/art.1780390423","volume":"39","author":"M Kuwana","year":"1996","unstructured":"Kuwana M, Fujii T, Mimori T, Kaburaki J (1996) Enhancement of anti-DNA topoisomerase I antibody response after lung cancer in patients with systemic sclerosis: a report of two cases. Arthritis Rheum 39:686\u201391","journal-title":"Arthritis Rheum"},{"key":"3288_CR12","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/art.1780310309","volume":"31","author":"N Rothfield","year":"1988","unstructured":"Rothfield N, Kurtzman S, Vazgues-Abad D, Charron C, Daniels L, Greenberg B (1988) Association of antitopoisomerase I with cancer. Arhritis Rheum 31:378\u201385","journal-title":"Arhritis Rheum"},{"key":"3288_CR13","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s100670050029","volume":"19","author":"M Higuchi","year":"2000","unstructured":"Higuchi M, Horiuchi T, Ishibashi N, Yoshizawa S, Niho Y, Nagasawa K (2000) Anticentromere antibody as a risk factor for cancer in patients with systemic sclerosis. Clin Rheumatol 19:123\u201326","journal-title":"Clin Rheumatol"},{"key":"3288_CR14","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/BOR.0b013e32834ff2e8","volume":"24","author":"J Barnes","year":"2012","unstructured":"Barnes J, Mayes MD (2012) Epidemiology of systemic sclerosis: incidence, prevalence, survival, risk factors, malignancy, and environmental triggers. Curr Opin Rheumatol 24:165\u201370","journal-title":"Curr Opin Rheumatol"},{"issue":"6","key":"3288_CR15","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/BOR.0000000000000222","volume":"27","author":"AA Shah","year":"2015","unstructured":"Shah AA, Casciola-Rosen L (2015) Cancer and scleroderma: a paraneoplastic disease with implications for malignancy screening. Curr Opin Rheumatol 27(6):563\u201370. doi: 10.1097\/BOR.0000000000000222","journal-title":"Curr Opin Rheumatol"},{"key":"3288_CR16","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/BF00283732","volume":"81","author":"G Rittner","year":"1988","unstructured":"Rittner G, Schwanitz G, Baur MP, Black CM, Welsh KI, K\u00fchnl P et al (1988) Family studies in scleroderma (systemic sclerosis) demonstrating an HLA-linked increased chromosomal breakage rate in cultured lymphocytes. Hum Genet 81:64\u201370","journal-title":"Hum Genet"},{"key":"3288_CR17","first-page":"837","volume":"18","author":"DJ Wolff","year":"1991","unstructured":"Wolff DJ, Needleman BW, Wasserman SS, Schwartz S (1991) Spontaneous and clastogen induced chromosomal breakage in scleroderma. J Rheumatol 18:837\u201340","journal-title":"J Rheumatol"},{"key":"3288_CR18","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.3899\/jrheum.100398","volume":"37","author":"J Avouac","year":"2010","unstructured":"Avouac J, Borderie D, Ekindjian OG, Kahan A, Allanore Y (2010) High DNA oxidative damage in systemic sclerosis. J Rheumatol 37:2540\u201347","journal-title":"J Rheumatol"},{"key":"3288_CR19","doi-asserted-by":"crossref","first-page":"398","DOI":"10.3109\/03009741003685640","volume":"39","author":"EP Martins","year":"2010","unstructured":"Martins EP, Fuzzi HT, Kayser C, Alarcon RT, Rocha MG, Chauffaille ML et al (2010) Increased chromosome damage in systemic sclerosis in skin fibroblasts. Scand J Rheumatol 39:398\u2013401","journal-title":"Scand J Rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-016-3288-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-016-3288-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-016-3288-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T04:59:31Z","timestamp":1559105971000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-016-3288-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,27]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["3288"],"URL":"https:\/\/doi.org\/10.1007\/s10067-016-3288-8","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,27]]}}}